新天药业
(002873)
| 流通市值：25.63亿 | | | 总市值：26.49亿 |
| 流通股本：2.24亿 | | | 总股本：2.32亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 177,321,934.57 | 953,981,876.69 | 775,665,238.78 | 525,906,384.4 |
| 营业收入 | 177,321,934.57 | 953,981,876.69 | 775,665,238.78 | 525,906,384.4 |
| 二、营业总成本 | 158,936,096.94 | 870,959,516.68 | 673,526,886.21 | 471,903,420.73 |
| 营业成本 | 39,310,123.85 | 218,758,188.59 | 177,364,026.95 | 120,334,082.13 |
| 税金及附加 | 3,439,689.93 | 13,044,445.45 | 11,436,170.86 | 6,862,890.46 |
| 销售费用 | 77,379,857.99 | 437,539,037.98 | 338,806,958.11 | 252,220,454.72 |
| 管理费用 | 29,901,573.65 | 151,477,434.98 | 111,936,656.49 | 72,697,700.27 |
| 研发费用 | 5,233,578.17 | 38,134,596.2 | 22,916,119.46 | 12,828,436.19 |
| 财务费用 | 3,671,273.35 | 12,005,813.48 | 11,066,954.34 | 6,959,856.96 |
| 其中:利息费用 | 3,849,768.33 | 11,803,742.65 | 11,550,760.76 | 7,200,651.95 |
| 其中:利息收入 | 199,212.87 | 924,332.01 | 351,273.87 | 324,782.25 |
| 加:公允价值变动收益 | 15,722.58 | -17,244.12 | -17,244.12 | -10,650.78 |
| 加:投资收益 | - | -707,206.84 | 0.16 | - |
| 资产处置收益 | 32,466.11 | 0 | - | - |
| 资产减值损失(新) | - | -630,015.53 | -451,297.18 | -423,956.97 |
| 信用减值损失(新) | -1,088,507.26 | 3,310,548.56 | -3,017,442.17 | -2,677,045.78 |
| 其他收益 | 1,200,180.06 | 8,764,202.42 | 5,354,623.2 | 4,538,121.82 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 18,545,699.12 | 93,742,644.5 | 104,006,992.46 | 55,429,431.96 |
| 加:营业外收入 | 84,036.61 | 371,326.17 | 277,859.53 | 215,386.87 |
| 减:营业外支出 | 312,932.77 | 1,697,285.37 | 1,328,325.87 | 76,107.07 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 18,316,802.96 | 92,416,685.3 | 102,956,526.12 | 55,568,711.76 |
| 减:所得税费用 | 2,744,845.41 | 11,545,623.23 | 15,244,857.13 | 9,241,079.69 |
| 六、净利润 | 15,571,957.55 | 80,871,062.07 | 87,711,668.99 | 46,327,632.07 |
| 持续经营净利润 | 15,571,957.55 | 80,871,062.07 | 87,711,668.99 | 46,327,632.07 |
| 归属于母公司股东的净利润 | 15,571,957.55 | 80,871,062.07 | 87,711,668.99 | 46,327,632.07 |
| (一)基本每股收益 | 0.07 | 0.35 | 0.38 | 0.2 |
| (二)稀释每股收益 | 0.06 | 0.33 | 0.36 | 0.19 |
| 八、其他综合收益 | - | -66,552,729.6 | - | - |
| 归属于母公司股东的其他综合收益 | - | -66,552,729.6 | - | - |
| 九、综合收益总额 | 15,571,957.55 | 14,318,332.47 | 87,711,668.99 | 46,327,632.07 |
| 归属于母公司股东的综合收益总额 | 15,571,957.55 | 14,318,332.47 | 87,711,668.99 | 46,327,632.07 |
| 公告日期 | 2024-04-27 | 2024-04-12 | 2023-10-30 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |